Lau, C.S.; Thundyil, J.; Oh, M.L.H.; Phua, S.K.; Liang, Y.L.; Li, Y.; Huo, J.; Huang, Y.; Zhang, B.; Xu, S.;
et al. Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster. Antibodies 2022, 11, 70.
https://doi.org/10.3390/antib11040070
AMA Style
Lau CS, Thundyil J, Oh MLH, Phua SK, Liang YL, Li Y, Huo J, Huang Y, Zhang B, Xu S,
et al. Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster. Antibodies. 2022; 11(4):70.
https://doi.org/10.3390/antib11040070
Chicago/Turabian Style
Lau, Chin Shern, John Thundyil, May Lin Helen Oh, Soon Kieng Phua, Ya Li Liang, Yanfeng Li, Jianxin Huo, Yuhan Huang, Biyan Zhang, Shengli Xu,
and et al. 2022. "Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster" Antibodies 11, no. 4: 70.
https://doi.org/10.3390/antib11040070
APA Style
Lau, C. S., Thundyil, J., Oh, M. L. H., Phua, S. K., Liang, Y. L., Li, Y., Huo, J., Huang, Y., Zhang, B., Xu, S., & Aw, T. C.
(2022). Neutralizing and Total/IgG Spike Antibody Responses Following Homologous CoronaVac vs. BNT162b2 Vaccination Up to 90 Days Post-Booster. Antibodies, 11(4), 70.
https://doi.org/10.3390/antib11040070